The investigation launched with the Competition Board (Board) decisions dated 28.03.2024, numbered 24-24/593-M and dated 20.03.2025, numbered 25-11/262-M on the economic unity composed of Novo Holdings A/S,  Novo Nordisk A/S, Novo Nordisk Sağlık Ürünleri Tic. Ltd. Şti., Novonesis A/S, Novozymes Berlin GmbH., Novozymes Enzim Dış Ticaret Ltd. Şti., Novozymes France S.A.S., Novozymes North America, Inc., Novozymes Switzerland AG, Synergia Life Sciences Pvt. Ltd., CHR Hansen A/S and CHR Hansen Gıda San. ve Tic. AŞ (NOVONESIS) to determine if it violated Article 6 of the Act no 4054 (Act no 4054) by engaging in conduct with an exclusionary nature which could obstruct the activities of its competitors has been concluded.

In its meeting of 23.10.2025, the Board decided that NOVONESIS held dominant position in the markets for the (I) asparaginase enzyme, (ii) fungal alpha amylase enzyme, and (iii) glucoamylase enzyme, and that the economic unity concerned violated Article 6 of the Act no 4054

• Through its  best price guarantee clauses and discount system aimed at creating loyalty in the asparaginase enzyme market,
• Through its discount system aimed at creating loyalty in the fungal alpha amylase market, and
• Through its exclusive agreements and discount system aimed at creating loyalty in the glucoamylase enzyme market,

and imposed an administrative fine of 284,509,319.04 TL on the undertaking.

However, since it was found that Novo Holdings A/S, Novo Nordisk A/S  and Novo Nordisk Sağlık Ürünleri Tic. Ltd. Şti. did not have any operations in the Turkish industrial enzymes market, it was decided that there was no grounds to impose fines on these undertakings.

With the same decision, the Board also concluded that the “Readjusted Alliance Agreement,” signed between Novonesis A/S and DSM Nutritional Products AG on 12.12.2007 concerning the phytase enzyme benefited from the block exemption under the scope of the Block Exemption Communiqué on Specialization Agreements, no 2013/3.

In Türkiye, NOVONESIS is operating in the sale of industrial enzymes which are used as inputs in various sectors including pharmaceuticals, food, cleaning and hygiene, textile, paper and leather.